product summary
Loading...
company name :
Alomone Labs
product type :
chemical
product name :
Co 102862
catalog :
C-160
more info or order :
image
image 1 :

Alomone Labs Co 102862 inhibits NaV1.7 channel currents in HEK293cells. - A. Time course of current reversible inhibition by 50 MCo 102862(#C-160). Currents were elicited by a voltage ramp from a holding potential of -100 mV to 60 mV (30 ms) delivered every 10 seconds. B. Example traces of current response to voltage ramp stimulation before and during application of 50 M Co 102862.
product information
CAT :
C-160
SKU :
C-160_10 mg
Product Name :
Co 102862
Group Type :
Non Antibodies
Product Type :
S. Molecules
Accession :
https://www.uniprot.org/uniprotkb/P26441/entry
Peptide confirmation :
Confirmed by amino acid analysis and mass spectrometry
Storage After Reconstitution :
The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods (up to 6 months), small aliquots should be stored at -20°C. We do not recommend storing the product in working solutions for longer than a few days. Avoid multiple freeze-thaw cycles.
Storage before Reconstitution :
The product is shipped as a lyophilized powder at room temperature. Upon receipt, store the product at -20°C. Protect from moisture.
Shipping and storage :
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C
Product Page - Scientific background :
Voltage-gated Na+ channels play key roles in determining neuronal excitability1,2. Voltage- and use-dependent blockage of voltage-gated Na+ channels appear to be important in the mechanism of action of many anticonvulsants (e.g. phenytoin (PHT), carbamazepine (CBZ) and lamotrigine (LTG)), local anesthetics (e.g. lidocaine and bupivacaine) and Class I antiarrhythmics3-10.Co 102862 is a potent, broad spectrum and state-dependent blocker of neuronal voltage-gated Na+ channels that interacts selectively with inactivated states as opposed to resting states of the channel11. IC50 values are 0.28-15.9 μM in rat hippocampal neurons11.Co 102862 is an anticonvulsant, demonstrating potent activity in rodent models of tonic/clonic and partial-complex seizures12.
Supplier :
Alomone Labs
Target :
NaV Na+ channels
Long Description :
Co 102862 (#C-160) is a highly pure, synthetic, and biologically active compound.
Short Description :
A Potent, State-Dependent Blocker of Neuronal NaV Channels
MW :
273.3
Synonyms :
V102862
Source :
Synthetic
Molecular formula :
C14H12FN3O2.
Effective Concentration :
0.1-200 μM
Activity :
Co 102862 is a potent, broad spectrum and state-dependent blocker of neuronal voltage-gated Na+ channels that interacts selectively with inactivated states as opposed to resting states of the channel1. IC50 values are 0.28-15.9 µM in rat hippocampal neurons2. It is an anticonvulsant, demonstrating potent activity in rodent models of tonic/clonic and partial-complex seizures3.
Reconstitution and Solubility :
DMSO. Centrifuge all product preparations before use (10000 x g 5 min).
Solubility :
DMSO. Centrifuge all product preparations before use (10000 x g 5 min).
Storage of solutions :
Up to four weeks at 4°C or three months at -20°C.
Lead Time :
1-2 Business Days
Country of origin :
Israel/IL
Applications key :
Application key: FC- Flow cytometry, IFC- Indirect flow cytometry, IHC- Immunohistochemistry,LCI- Live cell imaging, Calcium imaging assay,Cell survival assay, Electrophysiology, Neurite outgrowth assay.
Purity :
>96% (HPLC)
CAS No :
181144-66-1
Form :
Lyophilized powder.
Comment :
Contact Alomone Labs for technical support and product customization
UNSPSC :
41116134
Bioassay Tested :
Yes
Chemical Name :
2-[[4-(4-Fluorophenoxy)phenyl]methylene]hydrazinecarboxamide.
more info or order :
company information

Alomone Labs
Jerusalem BioPark (JBP), Hadassah Ein Kerem
P.O. Box 4287
Jerusalem 9104201
P.O. Box 4287
Jerusalem 9104201
info@alomone.com
http://www.alomone.com972 2 531 8002
headquarters: Israel
related products
browse more products
questions and comments